Germany · Delayed Price · Currency is EUR Nipro Company Description
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses.
Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ-related products, functional products, dialysis products, cell cultures, hospital products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products; and operates dialysis and training centers.
The company’s Pharmaceutical-Related business engages in the contract manufacturing of pharmaceutical products with containers for combination products, including injectable kit products consigned by other pharmaceutical companies; and provides injectable, oral drugs products.
In addition, its Pharma Packaging business offers pharmaceutical packaging containers and glass tubing, such as molded components for vials, syringes, rubber stoppers, and devices used to administer pharmaceuticals; and glass for thermos bottles, lighting and containers for combination products, glass equipment, as well glass for ampoules.
Further, the company serves customers in Japan, the Americas, Europe, and rest of Asia. Nipro Corporation was founded in 1947 and is based in Settsu, Japan.
| Country | Japan |
| Founded | 1947 |
| Industry | Orthopedic, Prosthetic, and Surgical Appliances and Supplies |
| Employees | 39,168 |
| CEO | Yoshihiko Sano |
Contact Details
Address: 3-26, Senriokashinmachi Settsu, 566-8510 Japan | |
| Phone | 81 6 6310 6910 |
| Website | nipro.co.jp |
Stock Details
| Ticker Symbol | 5FA |
| Exchange | Frankfurt Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Yoshihiko Sano | Chief Executive Officer |